By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Enanta Pharmaceuticals, Inc. 

500 Arsenal Street

Watertown  Massachusetts  02472  U.S.A.
Phone: 617-607-0800 Fax: 617-607-0530


SEARCH JOBS


Industry
Pharmaceutical






Company News
Enanta Pharmaceuticals, Inc. Announces Data On Eight-Week Treatment Of AbbVie (ABBV)’s VIEKIRAX (Ombitasvir/Paritaprevir/Ritonavir Tablets) + EXVIERA (Dasabuvir Tablets) In Patients With Genotype 1b Chronic Hepatitis C 9/23/2016 9:31:01 AM
Enanta Pharmaceuticals, Inc. To Present At Two Upcoming Investor Conferences 8/29/2016 8:33:17 AM
Enanta Pharmaceuticals, Inc. Reports Financial Results For Its Fiscal Third Quarter Ended June 30, 2016 8/9/2016 10:46:40 AM
Enanta Pharmaceuticals, Inc. Announces The U.S.FDA Has Approved AbbVie (ABBV)’s New, Once-Daily VIEKIRA XR (Dasabuvir, Ombitasvir, Paritaprevir And Ritonavir) For The Treatment Of Genotype 1 Chronic Hepatitis C Virus 7/26/2016 10:30:35 AM
Enanta Pharmaceuticals, Inc. To Host Conference Call On August 8 At 4:30 P.M. ET To Discuss Financial Results For Its Fiscal Third Quarter Ended June 30, 2016 7/18/2016 9:56:39 AM
Enanta Pharmaceuticals, Inc. Initiates Proof-Of-Concept Study With Pan-Genotypic Cyclophilin Inhibitor EDP-494 In Patients With Genotype 1 Or Genotype 3 Chronic Hepatitis C Virus 6/20/2016 10:44:03 AM
Enanta Pharmaceuticals, Inc. To Present At Two Upcoming Investor Conferences 6/2/2016 9:58:06 AM
Enanta Pharmaceuticals, Inc. Reports Financial Results For Its Fiscal Second Quarter Ended March 31, 2016 5/10/2016 11:57:40 AM
Enanta Pharmaceuticals, Inc. To Host Conference Call On May 9 At 4:30 P.M. ET To Discuss Financial Results For Its Fiscal Second Quarter Ended March 31, 2016 4/28/2016 10:21:45 AM
Enanta Pharmaceuticals, Inc. To Present At The Deutsche Bank (DB) 41st Annual Healthcare Conference Presentation To Be Webcast On May 4, 2016 At 8:00 A.M. ET 4/26/2016 12:09:39 PM
12345678910...
//-->